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Abstract
Background: Stress echocardiography (SE) is dependent on subjective interpretations. As a prelude to the
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) Trial,
potential sites were required to submit two SE, one with moderate or severe left ventricular (LV) myocardial
ischemia and one with mild ischemia. We evaluated the concordance of site and core lab interpretations.
Methods: Eighty-one SE were submitted from 41 international sites. Ischemia was classified by the number of new
or worsening segmental LV wall motion abnormalities (WMA): none, mild (1 or 2) or moderate or severe (3 or
more) by the sites and the core lab.
Results: Core lab classified 6 SE as no ischemia, 35 mild and 40 moderate or greater. There was agreement
between the site and core in 66 of 81 total cases (81 %, weighted kappa coefficient [K] =0.635). Agreement was
similar for SE type - 24 of 30 exercise (80 %, K = 0.571) vs. 41 of 49 pharmacologic (84 %, K = 0.685). The agreement
between poor or fair image quality (27 of 36 cases, 75 %, K = 0.492) was not as good as for the good or excellent
image quality cases (39 of 45 cases, 87 %, K = 0.755). Differences in concordance were noted for degree of ischemia
with the majority of discordant interpretations (87 %) occurring in patients with no or mild LV myocardial ischemia.
Conclusions: While site SE interpretations are largely concordant with core lab interpretations, this appears
dependent on image quality and the extent of WMA. Thus core lab interpretations remain important in clinical trials
where consistency of interpretation across a range of cases is critical.
Trial registration: ClinicalTrials.gov NCT01471522
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Background
Stress echocardiography (SE) is widely used for diagnosis,
risk stratification, and prognosis of patients with known
or suspected coronary artery disease and has reason-
able sensitivity and specificity for clinical decision
making [1, 2]. Since SE relies on the subjective assess-
ment of wall motion abnormality (WMA) there is the
potential for differences in interpretation by different
readers to influence its generalizability. In fact, SE inter-
pretations at individual institutions may be influenced by
local standards and conventions and thus if reviewed at
other institutions might result in different diagnoses espe-
cially in borderline cases [3]. Guidelines have been devel-
oped in order to reduce inter-reader variability [4].
However, there is still the potential for less agreement in
SE readings when compared beyond a single institution,
such as when utilized in multicenter studies, and this risk
is a major justification for the use of a centralized core
laboratory interpretation. We utilized SE from sites par-
ticipating in an international multicenter trial in order to
* Correspondence: MHPICARD@mgh.harvard.edu
1Cardiac Ultrasound Laboratory, Massachusetts General Hospital and Harvard
Medical School, 55 Fruit Street Yawkey 5E, Boston, MA 02114, USA
Full list of author information is available at the end of the article
© 2015 Kataoka et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Kataoka et al. Cardiovascular Ultrasound  (2015) 13:47 
DOI 10.1186/s12947-015-0043-2
examine the concordance between site and core labora-
tory SE interpretation and to identify factors which might
influence this concordance.
Methods
Subject population
SE exams submitted in the pre-enrollment site certifica-
tion phase of the International Study of Comparative
Health Effectiveness with Medical and Invasive Ap-
proaches (ISCHEMIA) Trial were studied. The ISCHE-
MIA Trial is a randomized study comparing an initial
invasive strategy of cardiac catheterization, revasculariza-
tion, and optimal medical therapy with a conservative
strategy of optimal medical therapy alone among stable
patients with at least moderate myocardial ischemia [5, 6].
As a prelude to this trial, participating sites were encour-
aged to submit stress imaging studies to the core labora-
tories. The SE could be any mode of stress (exercise or
pharmacologic) and could demonstrate any degree of is-
chemia from none to severe, as the goals of this phase
were to determine if the digital submissions could be
transmitted smoothly and viewed on the core lab work-
station, and also to assess if the site could differentiate
varying degrees of ischemia. Ninety two digital SEs in
quad screen format were electronically submitted to the
echocardiography core laboratory at the Massachusetts
General Hospital from April 2012 to April 2013. Of
these 92 cases, 11 were excluded for technical reasons
(very poor image quality or non-compatible format),
leaving 81 cases submitted from 41 sites from 12 countries
(Australia, Australia, Canada, Germany, Hungary, Italy,
Korea, Macedonia, Poland, Spain, United Kingdom and
United States). Demographic and clinical data were not
provided to the core lab. The mode of stress was exercise
in 30, pharmacologic in 49 (dobutamine, dipyridamole or
adenosine) and unknown in 2. Fourteen of the cases used
contrast agents for left ventricular (LV) opacification. The
institutional review board of Massachusetts General
Hospital approved the study protocol.
Core laboratory assessments
Two experienced core lab echocardiographers who were
blinded to the site interpretations interpreted the SE to-
gether for segmental WMAs. Standard interpretations
were performed assessing each segment at baseline and
peak stress using a modified 17 segment model with seg-
ment 17, the apical cap, excluded [7]. Significant WMA
was defined as stress-induced severe hypokinesis or
akinesis and the degree of LV myocardial ischemia was
classified by the number of segments with new or worsen-
ing stress-induced segmental WMAs. Moderate or greater
LV myocardial ischemia was defined as associated with an
approximately 5 % per year rate of MI or death. Based on
literature review and expert consensus, this was determined
as occurring when at least 3 segments, developed signifi-
cant WMA during SE [8]. Thus, mild ischemia was defined
as one or two segments with stress-induced WMAs.
Core lab determination of image quality was based on
adequacy of LV border definition and classified as excel-
lent, good, fair, and poor. Excellent image quality had
complete LV endocardial border definition. Good image
quality had visualization of 88 - 99 % of the endocardial
borders (14 or more segments). Fair image quality had
visualization of 70 - 88 % of the LV endocardial borders
(11–13 segments). Poor image quality had visualization
of less than 70 % LV endocardial border.
Statistical analysis
Concordance between site interpretation and core lab
interpretations was examined in total and as a function
of mode of stress, degree of myocardial ischemia, image
quality, and the site’s geographic location. All categorical
variables are presented as proportions. All analyses were
performed using MedCalc software ver. 12.7.1.0 (MedCalc
Software, Ostend, Belgium). Comparisons of concordance
was assessed by Chi-square testing and weighted kappa
coefficients (K). The value of K was graded as following: 0
to less than 0.4 was poor agreement; equal to or greater
than 0.4 to less than 0.6 was moderate agreement; equal
to or greater than 0.6 to less than 0.8 was good agreement;
and equal to or greater than 0.8 to 1.0 was excellent agree-
ment [9]. A p-value of less than 0.05 was considered
statistically significant.
Results
As seen in Table 1, there was agreement between the site
and core lab interpretations in 66 of the 81 SE cases
(81.4 %). Kappa was 0.635 and considered good agree-
ment. From this table it is seen that in 13 of the 15 dis-
crepancies the site over-interpreted the extent of
ischemia compared to the core lab.
Concordance by stress mode
Table 2 shows the agreements as a function of the
method of stress. There was concordance of interpret-
ation in 24 of the 30 exercise SE cases (80.0 %) and 41
of the 49 pharmacologic SE cases (83.6 %). The
Table 1 Agreement of LV myocardial ischemia in a total of 81
cases
MGH Echo core lab
No ischemia Mild Moderate or severe
Site No ischemia 0 0 0
Mild 4 28 2
Moderate or severe 2 7 38
K = 0.635
Abbreviation: K, weighted kappa coefficients
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agreement for exercise SE was considered moderate
(K = 0.571) and good (K = 0.685) for the pharmaco-
logic mode of stress. In addition, there were no signifi-
cant statistical differences in concordance by Chi-square
test (Table 3).
Concordance as a function of image quality
Table 4 shows the agreements stratified by image quality.
There was agreement in 27 of the 36 cases with poor or
fair image quality (75.0 %) and in 39 of 45 cases with the
good or excellent image quality (86.6 %). The Κappa co-
efficient was 0.492 for the poor or fair image quality
cases (moderate agreement) and 0.755 for the good or
excellent image quality cases (good agreement). How-
ever, there were no significant statistical differences in
concordance by Chi-square test (Table 5).
Concordance by degree of LV myocardial ischemia
Table 6 shows comparisons of concordance by degree of
LV myocardial ischemia. Significant differences in con-
cordance were noted based on the degree of ischemia.
Thirteen of the 15 discordant interpretations were in
patients with no or mild LV myocardial ischemia accord-
ing to the core lab (86.6 %).
Role of contrast agents
Echocardiographic contrast agents were used in only a
small number of the cases. Even though there was con-
cordant interpretations in 13 of the 14 contrast cases,
when these 14 cases were excluded from the analysis
there was no significant differences in the results most
likely due to the small sample size.
Discussion
While SE is an important method to diagnose coronary
artery disease, it is based on the subjective assessment of
changes in LV WMA. Thus there is the potential for
variability in interpretation amongst readers. In a prel-
ude to the multicenter ISCHEMIA Trial, we examined
the degree of agreement between enrolling site and core
lab SE interpretations of cases that were representative
of varying degrees of myocardial ischemia. We found
that while agreement in aggregate is good, there are vari-
ables which are associated with lower degrees of inter-
reader agreement. These include the degree of myocardial
ischemia and the image quality. Such discordances high-
light the importance of the use of a core lab in multicenter
trials.
Specifically, there was agreement between local site
and core lab in the interpretation of the degree of myo-
cardial ischemia in 81 % of the cases. In the cases where
Table 2 Agreement of LV myocardial ischemia by stress type
(exercise and pharmacological)
MGH Echo core lab
Exercise (N = 30) No ischemia Mild Moderate or severe
Site No ischemia 0 0 0
Mild 1 8 1
Moderate or severe 1 3 16
K = 0.571
Pharmacological (N = 49)
No ischemia 0 0 0
Mild 3 20 1
Moderate or severe 1 3 21
K = 0.685
Abbreviation: K, weighted kappa coefficients
Table 3 Comparisons of concordance in stress type
(exercise vs pharmacological stress)
Concordant read
(n = 65)
Discordant read
(N = 14)
χ2 p-value
Exercise stress (N = 30) 24 6
Pharmacological stress 41 8
(N = 49)
P = 0.91
Table 4 Agreement of LV myocardial ischemia by image quality
(poor or fair and good or excellent)
MGH Echo core lab
Poor or Fair (N = 36) No ischemia Mild Moderate or severe
Site No ischemia 0 0 0
Mild 2 9 1
Moderate or severe 2 4 18
K = 0.492
Good or Excellent (N = 45)
No ischemia 0 0 0
Mild 2 19 1
Moderate or severe 0 3 20
K = 0.755
Abbreviation: K, weighted kappa coefficients
Table 5 Comparisons of concordance in image quality
(poor or fair vs good or excellent)
Concordant read
(n = 66)
Discordant read
(N = 15)
χ2 p-value
Poor or Fair 27 9
Image quality (N = 36)
Good or Excellent 39 6
Image quality (N = 45)
P = 0.29
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there was disagreement, the majority (87 %) of these
were determined by the core lab to have no or mild
myocardial ischemia (defined as 0, 1 or 2 positive seg-
ments) but were interpreted as more extensive ischemia
by the local site. Thus while one might have hypothe-
sized that a major source of discrepant interpretations
would be when small regions of stress induced WMAs
are missed, in fact the major source of discrepancy was a
tendency for local interpretations to over-estimate the
extent of stress induced WMA. One can speculate that
this may reflect a cognitive bias as the site interpreter
might have been influenced by the clinical information
about the patient, exercise performance, symptoms dur-
ing the test or the stress ECG to interpret the stress
echocardiographic wall motion to reflect more extensive
ischemia than was present. The core lab interpretation
was immune to such bias as the core lab did not have
access to clinical or stress test data. An alternative ex-
planation for our findings of more disagreement when
myocardial ischemia is absent or mild during SE is that
larger extent of, or more severe degrees of, WMA are
easier to appreciate and thus the agreement would be
better in these cases. Previous studies of inter-
institutional observer agreement of SE have also found
better agreement when the coronary artery disease is
more extensive [4, 10, 11].
It is not surprising that 60 % of the disagreements oc-
curred in cases where images were graded as fair or poor
due to reduced visualization of left ventricular endocar-
dium. Hoffman and colleagues previously identified image
quality as an important factor influencing inter-observer
variability in the interpretation of dobutamine stress echo-
cardiograms [4]. Interestingly, even though image quality
has improved in the 17 years since that report, the findings
remain similar. Our study also extends those findings by
examining exercise SE. The Kappa statistic was better for
pharmacologic SE than for exercise SE. This reduced preci-
sion in agreement with exercise stress echocardiography
may reflect the fact that imaging can be more challenging
with exercise especially in these beating rapidly immediately
after peak exercise than when the patient remains supine
for the entire pharmacologic stress test. Since the sample
size for exercise stress echo was smaller than for pharmaco-
logic stress, this difference should be taken with caution.
Prior studies that have examined this issue typically
have utilized single centers [12] or involved multiple ex-
perienced centers [3, 4]. Our study extends the observa-
tions to a more “real world” experience utilizing active
clinical programs from around the world with various
levels of experience.
While variability in discrimination of different degrees
of ischemia may not be as important for the diagnosis of
coronary artery disease (that is, establishing the presence
or absence of any coronary disease), it does have implica-
tions for assessment of prognosis or for trial enrollment.
For example, the ischemia entry criterion for the ISCHE-
MIA Trial is the presence of moderate or greater myocar-
dial ischemia on stress testing. Our observations suggest
that without core lab oversight, patients with less than
moderate ischemia might be enrolled, and this could im-
portantly affect the results. While the Clinical Outcomes
Utilizing Revascularization and Aggressive Drug Evaluation
(COURAGE) Trial did not show a benefit of revasculariza-
tion to reduce major adverse cardiovascular events com-
pared to optimal medical therapy in patients with stable
coronary artery disease, a substudy demonstrated that the
greatest reduction in ischemia as measured by myocardial
perfusion imaging occurred in those with moderate to se-
vere ischemia who underwent percutaneous revasculariza-
tion [13, 14]. Analysis of outcomes based on the degree of
ischemia was limited by small sample size. The ISCHEMIA
Trial aims to more clearly define the role of an invasive
strategy of routine angiography and complete revasculariza-
tion in stable coronary artery disease patients with moder-
ate or greater myocardial ischemia. Other clinical studies
have shown that the extent and severity of myocardial is-
chemia is well correlated with prognosis, again highlighting
the importance of accurate determination of not just the
presence but also the severity of myocardial ischemia [15].
Our observations highlight the importance of a core lab not
biased by the knowledge of the details of the patient and
stress test in order to assure proper composition of the trial
population.
The value of core lab interpretations has also been
demonstrated in the interpretation of electrocardiograms
in patients with acute coronary syndromes [16, 17].
These studies taken with ours show that the advantages
of core laboratory interpretations include standardized
assessments (especially when confounding variables are
present), lack of bias from other clinical data, and low
intra- and inter-observer variability.
Our study differs from prior studies examining inter-
observer variability in SE interpretation at expert centers
in that technologic advances have occurred and were in-
corporated into our cases. While prior studies included
a high proportion of videotape assessments, all of our
assessments were on digital images with harmonic im-
aging that were formatted for side by side rest and stress
Table 6 Comparisons of concordance in degree of LV
myocardial ischemia (no or mild vs moderate or severe)
Concordant
read (n = 66)
Discordant
read (N = 15)
χ2
p-value
No or mild ischemia by core
lab read (N = 41)
28 13
Moderate or severe ischemia
by core lab read (N = 40)
38 2
P < 0.01
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comparisons [3]. More recent updates to the original
studies by Hoffman confirm that technologic enhance-
ments such as digital image processing and harmonic
imaging lead to better SE interpretation agreements [18].
Our data suggest that at least part of this improvement
is due to the improvements that result in image quality.
While there may be different equipment, stress proto-
cols, scanning techniques, image acquisition protocols
and levels of expertise at different sites around the world,
our data did not demonstrate a difference in concordance
as a function of this geographic location.
Interpretation of stress echocardiograms is challenging
and prior studies have shown the value of educational ini-
tiatives [19]. An added benefit of core lab interpretations
is that the information can be passed back to the enrolling
site and improve subsequent quality and interpretations.
Limitations
There are several limitations in this study. First, due to
the restrictions of the pilot phase of this trial, we did not
have access to patient demographic data and thus we
cannot assess if such characteristics would influence
concordance. On the other hand, this enabled the core
lab to remain free of bias. Also we did not have access
to information about the site readers. Their years of
echocardiography experience might explain differences
in concordance. In fact, prior studies suggest that spe-
cific training and experience in SE is critical for accurate
interpretations [20, 21]. In this actively enrolling trial,
we do not yet have access to the coronary anatomy by
cardiac CT or coronary angiography and thus are unable
to assess concordance as a function of the location and
severity of coronary artery disease. It is expected that
use of contrast agents to enhance LV endocardial border
delineation would improve image quality and reduce
inter-observer interpretation variability. However, con-
trast was used in only 14 cases in this data set and so we
were unable to assess its benefit. There were differences
in the numbers of pharmacologic and exercise stress
cases that composed our population. While the sample
sizes of each population were sufficient for analysis, it is
possible that this difference might contribute to the dif-
ferences noted by modality. Lastly, SE in this trial did
not incorporate new technologies such as strain imaging
which would provide quantitative parameters that might
influence concordance.
Conclusions
We sought to assess the value of core lab interpretation
in a real world experience involving multiple enrolling
sites from multiple locations around the world with mul-
tiple levels of experience. While site SE interpretations
are comparable to core lab interpretations in many
cases, discrepancies occur in up to 20 %. The majority of
the discrepancies result from local site over-estimation
of the extent of ischemia. The major factors associated
with discordance of interpretation are the extent of indu-
cible ischemia and image quality. Thus, interpretations by
experienced and expert core laboratories remain import-
ant in clinical trials where consistency of interpretation
across a range of cases is critical.
Abbreviation
SE: Stress echocardiography; WMA: Wall motion abnormality;
ISCHEMIA: International study of comparative health effectiveness with
medical and invasive approaches; LV: Left ventricular; K: Weighted kappa
coefficients.
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